project id: TCGA-LUAD; case submitter id: TCGA-78-7159; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; state: released; a260 a280 ratio: 1.7; normal tumor genotype snp match: Yes; age at index: 60; days to birth: -22261; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1948; age at diagnosis: 22261; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage IA; ajcc pathologic t: T1; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1974.0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8255/3; primary diagnosis: Adenocarcinoma with mixed subtypes; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: No; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 1.1506849315068493; pack years smoked: 21.0; years smoked: 42.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 1.0; longest dimension: 1.1; oct embedded: No; shortest dimension: 0.7; portion submitter id: TCGA-78-7159-01A-11; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor nuclei: 70.0;